Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$3.56B |
| 2 |
Intel
INTC
|
+$1.76B |
| 3 |
Salesforce
CRM
|
+$1.35B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$864M |
| 5 |
Mastercard
MA
|
+$788M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$2.53B |
| 2 |
Toronto Dominion Bank
TD
|
+$1.95B |
| 3 |
PNC Financial Services
PNC
|
+$1.55B |
| 4 |
General Motors
GM
|
+$1.37B |
| 5 |
UnitedHealth
UNH
|
+$1.15B |
Sector Composition
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 12.41% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
AstraZeneca
AZN
$247B
| $71.9M | 0.02% |
+1,035,454
| New | +$71.9M |
|
302
ICF International
ICFI
$1.83B
| $71.7M | 0.02% |
653,831
| – | – |
|
303
First Advantage
FA
$2.75B
| $69.6M | 0.02% |
4,988,399
| – | – |
|
304
Essent Group
ESNT
$6.29B
| $68.1M | 0.02% |
1,700,000
+900,000
| +113% | +$36M |
|
305
PagSeguro Digital
PAGS
$2.78B
| $66.8M | 0.02% |
7,800,000
+4,306,166
| +123% | +$36.9M |
|
306
CCC Intelligent Solutions
CCCS
$6.37B
| $65.5M | 0.02% |
7,305,588
-1,499,480
| -17% | -$13.5M |
|
307
Atkore
ATKR
$2.06B
| $65.5M | 0.02% |
466,155
| – | – |
|
308
Chart Industries
GTLS
$8.95B
| $62.6M | 0.02% |
499,107
-360,594
| -42% | -$45.2M |
|
|
IBTX
309
DELISTED
Independent Bank Group, Inc.
IBTX
| $62.3M | 0.02% |
1,344,599
-1,102,003
| -45% | -$51.1M |
|
310
GSK
GSK
$82.2B
| $62.3M | 0.02% |
1,751,318
+1,140
| +0.1% | +$40.6K |
|
311
On Holding
ONON
$14B
| $61.5M | 0.02% |
1,980,610
| – | – |
|
312
Newmont
NEM
$87.1B
| $61.3M | 0.02% |
1,250,000
| – | – |
|
313
Fiserv
FI
$73B
| $60.7M | 0.02% |
536,700
| – | – |
|
314
Emerson Electric
EMR
$76B
| $59.6M | 0.02% |
684,009
+391
| +0.1% | +$34.1K |
|
315
Denali Therapeutics
DNLI
$2.07B
| $56.9M | 0.02% |
2,468,824
+208,182
| +9% | +$4.8M |
|
316
CrowdStrike
CRWD
$109B
| $55.9M | 0.02% |
407,470
-5,729,363
| -93% | -$786M |
|
|
AZUL
317
DELISTED
Azul
AZUL
| $54.1M | 0.02% |
7,570,322
-107,595
| -1% | -$769K |
|
318
Bentley Systems
BSY
$16.1B
| $52.2M | 0.01% |
1,213,743
| – | – |
|
319
Sempra
SRE
$54.8B
| $52.1M | 0.01% |
689,434
+56
| +0% | +$4.23K |
|
|
CHX
320
DELISTED
ChampionX
CHX
| $50.2M | 0.01% |
1,851,762
| – | – |
|
321
Unity
U
$18.4B
| $49.7M | 0.01% |
1,532,815
-138,469
| -8% | -$4.49M |
|
322
Bristol-Myers Squibb
BMY
$94B
| $49.2M | 0.01% |
709,449
| – | – |
|
323
Montrose Environmental
MEG
$1.05B
| $48.6M | 0.01% |
1,361,917
-610,178
| -31% | -$21.8M |
|
|
AZPN
324
DELISTED
Aspen Technology Inc
AZPN
| $48.5M | 0.01% |
211,701
| – | – |
|
|
LTHM
325
DELISTED
Livent Corporation
LTHM
| $48.3M | 0.01% |
2,223,481
+196,328
| +10% | +$4.26M |
|